Chemical Structure : PD0325901
CAS No.: 391210-10-9
Catalog No.: PC-42489Not For Human Use, Lab Use Only.
Mirdametinib (PD0325901) is a selective, non ATP-competitive MEK inhibitor with IC50 of 0.33 nM.
| Packing | Price | Stock | Quantity |
|---|---|---|---|
| 5 mg | $38 | In stock | |
| 10 mg | $58 | In stock | |
| 25 mg | $98 | In stock | |
| 50 mg | $158 | In stock | |
| 100 mg | $248 | In stock | |
| 250 mg | Get quote |
Bulk size, bulk discount!
Welcome credit card payment!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Mirdametinib (PD0325901) is a selective, non ATP-competitive MEK inhibitor with IC50 of 0.33 nM.
PD0325901 markedly inhibits ERK phosphorylation and growth of both BRAF mutant and wild-type melanoma cell lines with IC50 in the nanomolar range.
PD0325901 significantly reduces the growth of papillary thyroid carcinoma cells in vitro and in vivo; orally active.
| M.Wt | 482.1931 | |
| Formula | C16H14F3IN2O4 | |
| Appearance | Solid | |
| Storage |
|
|
| Solubility |
DMSO: ≥ 56 mg/mL |
|
| Chemical Name/SMILES |
Benzamide, N-[(2R)-2,3-dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]- |
|
1. Barrett SD, et al. Bioorg Med Chem Lett. 2008 Dec 15;18(24):6501-4.
2. Ciuffreda L, et al. Neoplasia. 2009 Aug;11(8):720-31.
3. Henderson YC, et al. Mol Cancer Ther. 2010 Jul;9(7):1968-76.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright